FDA Approves Opioid Pain Reliever with Required Risk Reduction Plan
Thu, 16 Jul 2009 16:05:00 UTC
The U.S. Food and Drug Administration today approved Onsolis, medication intended for certain patients with cancer to help manage breakthrough pain – severe flares of pain that break through regular pain medication.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm172366.htm
